Unknown

Dataset Information

0

Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells.


ABSTRACT: Genetic modification of specific genes is emerging as a useful tool to enhance the functions of antitumor T cells in adoptive immunotherapy. Current advances in CRISPR/Cas9 technology enable gene knockout during in vitro preparation of infused T-cell products through transient transfection of a Cas9-guide RNA (gRNA) ribonucleoprotein complex. However, selecting optimal gRNAs remains a major challenge for efficient gene ablation. Although multiple in silico tools to predict the targeting efficiency have been developed, their performance has not been validated in cultured human T cells. Here, we explored a strategy to select optimal gRNAs using our pooled data on CRISPR/Cas9-mediated gene knockout in human T cells. The currently available prediction tools alone were insufficient to accurately predict the indel percentage in T cells. We used data on the epigenetic profiles of cultured T cells obtained from transposase-accessible chromatin with high-throughput sequencing (ATAC-seq). Combining the epigenetic information with sequence-based prediction tools significantly improved the gene-editing efficiency. We further demonstrate that epigenetically closed regions can be targeted by designing two gRNAs in adjacent regions. Finally, we demonstrate that the gene-editing efficiency of unstimulated T cells can be enhanced through pretreatment with IL-7. These findings enable more efficient gene editing in human T cells.

SUBMITTER: Ito Y 

PROVIDER: S-EPMC10783505 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells.

Ito Yusuke Y   Inoue Satoshi S   Nakashima Takahiro T   Zhang Haosong H   Li Yang Y   Kasuya Hitomi H   Matsukawa Tetsuya T   Wu Zhiwen Z   Yoshikawa Toshiaki T   Kataoka Mirei M   Ishikawa Tetsuo T   Kagoya Yuki Y  

Nucleic acids research 20240101 1


Genetic modification of specific genes is emerging as a useful tool to enhance the functions of antitumor T cells in adoptive immunotherapy. Current advances in CRISPR/Cas9 technology enable gene knockout during in vitro preparation of infused T-cell products through transient transfection of a Cas9-guide RNA (gRNA) ribonucleoprotein complex. However, selecting optimal gRNAs remains a major challenge for efficient gene ablation. Although multiple in silico tools to predict the targeting efficien  ...[more]

Similar Datasets

2023-07-14 | GSE237310 | GEO
| PRJNA994553 | ENA
| S-EPMC7575003 | biostudies-literature
| S-EPMC8024976 | biostudies-literature
| S-EPMC4231237 | biostudies-literature
| S-EPMC11681161 | biostudies-literature
| S-EPMC7461958 | biostudies-literature
| S-EPMC4766569 | biostudies-literature
| S-EPMC5714203 | biostudies-literature
| S-EPMC7018052 | biostudies-literature